Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor

Tranylcypromine and 6-trifluoroethyl thienopyrimidine hybrid as LSD1 inhibitor Discovery of new tranylcypromine derivatives as highly potent LSD1 inhibitors Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment Design and synthesis of benzylpiperidine inhibitors targeting the menin–MLL1 interface Phenothiazine-Based LSD1 Inhibitor Promotes T-Cell Killing Response of Gastric Cancer Cells Design, synthesis and biological evaluation of [1,2,4]triazolo[1,5-a]pyrimidines as potent lysine specific demethylase 1 (LSD1/KDM1A) inhibitors Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: A novel class of irreversible inhibitors of histone demethylase KDM1A Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utility